Yishan Wang

Mr. Yishan Wang

orcid

Research Focus & Metrics

Representative Publications

View All Publications
1 June 2026 in JCO Precision Oncology
Verified
Journal Article
Closed access
PHPeixuan He
Peixuan He
YWYishan Wang
Yishan Wang
NXNian Xie
Nian Xie
CLChengniang Liu
Chengniang Liu
PLPei Liu
Pei Liu
CFChun Fu
Chun Fu
PURPOSE: To address the growing incidence of endometrial cancer (EC), noninvasive detection methods are needed. Although self-sampling is proven for cervical cancer screening, its utility for EC detection via methylation analysis lacks robust evidence. This study aimed to validate this approach by evaluating the concordance and diagnostic accuracy of CDO1 / CELF4 methylation testing in self-collected samples compared with clinician-collected samples. METHODS: In this prospective cross-sectional study, paired self-collected (Evalyn Brush) and physician-collected cervical samples were obtained from women referred for hysteroscopy. CDO1 and CELF4 methylation levels were measured by qPCR. Method agreement was analyzed with Spearman correlation and Bland-Altman plots, and diagnostic performance was evaluated by the area under the ROC curve (AUC). RESULTS: Analysis of 142 participants revealed high agreement between self- and physician-collected samples, with significant correlations ( CDO1 R = 0.79, CELF4 R = 0.76; P < .05) and Bland-Altman analysis confirming minimal bias ( P > .05 for both genes). Self and physician sampling showed comparable efficacy for EC detection via CDO1 / CELF4 methylation, with AUCs of 0.930 and 0.896, respectively. Methylation levels (ΔCt) differed significantly ( P < .001) between EC (n = 33) and non-EC (n = 109) groups, regardless of the collection method. The diagnostic performance remained consistently high across premenopausal and postmenopausal subgroups. CONCLUSION: Self-collected vaginal samples for CDO1 / CELF4 methylation analysis demonstrate high agreement and diagnostic accuracy equivalent to physician-collected samples for EC detection. This self-sampling strategy represents a reliable, noninvasive, and patient-centric approach, showing potential for integration into future EC diagnosis strategies to improve accessibility and early detection. Future multicenter studies are warranted to validate its effectiveness in broader populations.

28 October 2026 in Pathogens
Verified
Journal Article
Open access
PDF file
MLMingzhu Li
Mingzhu Li
WZWei Zhang
Wei Zhang
YWYishan Wang
Yishan Wang
YZYun Zhao
Yun Zhao
LRLihua Ren
Lihua Ren
Lihui WeiLihui Wei
Lihui Wei
Background: High-risk HPV16/18 subtypes account for over 70% of cervical cancers, but should all HPV16/18-positive patients routinely undergo endocervical curettage (ECC)? Methods: A retrospective cohort study was conducted on 670 HPV16/18-positive patients who underwent colposcopy at Peking University People’s Hospital from 2021 to 2024. Stratified analysis was performed based on prior HPV infection history, current cervical cytology and HPV test results, transformation zone (TZ) type, and colposcopic impression. Primary outcome was the detection rate of cervical intraepithelial neoplasia above (CIN2)+ on final pathology and the additional diagnostic yield of ECC in the ECC subgroup. Results: Among the 670 HPV16/18-positive women, CIN2+ was identified in 32.5% (218/670); the CIN2+ group was significantly younger than the < CIN2 group (median 36.5 vs. 41.0 years, p < 0.001). A high-grade colposcopic impression (G2) steeply elevated the observed CIN2+ proportion to 100%, especially combined with high-grade cytology. In contrast, a Normal/G1 colposcopic finding effectively downgraded the risk to 4.8% in the presence of prior HPV negativity + low-grade cytology + visible TZ. Among the 523 ECC specimens, it is noteworthy that even when the final pathology was diagnosed as CIN2+, a considerably high proportion of patients (44.4–64.7%) remained free of lesions in the endocervical canal; in the colposcopy impression (G2) population, 68.1% of the ECC was normal. The incremental yield of ECC over directed biopsy was only 2.7% (14/523), and all 14 incremental cases occurred in TZ3 (100%). Among the 146 women meeting the composite low-risk profile (TZ1/2 combined with a Normal/G1 colposcopic impression), none had an incremental CIN2+ detection. Conclusion: Women with HPV16/18-positive CIN2+ lesions presented at a younger age. Approximately one-third were diagnosed with CIN2+, and more than half of these had normal ECC histology. With a low additional diagnostic rate observed, ECC provided incremental diagnostic benefit in only 2.7% of HPV16/18-positive women undergoing colposcopy, almost exclusively among patients with a Type 3 transformation zone. The composite low-risk profile identified a subgroup with an extremely low additional diagnostic yield of ECC; however, prospective validation is required before the omission of ECC in this subgroup can be recommended as a change in clinical practice.